{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "Organization",
      "@id": "https://preludetx.com/#organization",
      "name": "Prelude Therapeutics",
      "url": "https://preludetx.com/",
      "description": "Prelude Therapeutics is a leading precision oncology company developing innovative medicines in areas of high unmet need for cancer patients. Our pipeline features highly selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors – new approaches to clinically validated targets with transformative potential for patients. We are also leveraging our expertise in targeted protein degradation to […]"
    },
    {
      "@type": "WebPage",
      "@id": "https://directory.websdocs.com/business/prelude-therapeutics#asg",
      "name": "Prelude Therapeutics ASG Directory Profile",
      "url": "https://directory.websdocs.com/business/prelude-therapeutics",
      "isPartOf": {
        "@id": "https://preludetx.com/#organization"
      },
      "description": "Public business information published by the WebsDocs ASG Directory."
    }
  ]
}